Senate Resolution
S.Res. 270
A resolution designating June 6, 2025, as National Naloxone Awareness Day.
Primary Sponsor
Mark Kelly
Senator
Cosponsors
0
Quick Stats
Policy Area
Summary
This resolution would officially designate June 6, 2025, as National Naloxone Awareness Day. Naloxone is a medication that can reverse the effects of an opioid overdose, potentially saving lives. The resolution aims to raise awareness about the importance of this life-saving drug.
Latest Action
Referred to the Committee on the Judiciary. (text: CR S2238)
See this page through your district lens
Enter ZIP to personalize representatives and vote context.
Stay on top of this issue
Subscribe for weekly bill and representative updates.
This resolution would officially designate June 6, 2025, as National Naloxone Awareness Day. Naloxone is a medication that can reverse the effects of an opioid overdose, potentially saving lives. The resolution aims to raise awareness about the importance of this life-saving drug.
- Bill Number
- 270
- Sponsor
- Mark Kelly (D-AZ)
- Introduced
- 6/10/2025
- Status
- Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimou
- Policy Area
- Health
Data from Congress.gov
Fact Sheet
- Title
- A resolution designating June 6, 2025, as National Naloxone Awareness Day.
- Bill Number
- 270
- Sponsor
- Mark Kelly (D-AZ)
- Status
- Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimou
- Introduced
- 6/10/2025
- Summary
- This resolution would officially designate June 6, 2025, as National Naloxone Awareness Day. Naloxone is a medication that can reverse the effects of an opioid overdose, potentially saving lives. The resolution aims to raise awareness about the importance of this life-saving drug.
Data from Congress.gov
Public Opinions
Community submissions related to this bill.
No public opinions yet. Be the first to submit one for this bill.
Related Bills in Health
Empowering Patient Choice of Medical Care Act
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means
To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.
Referred to the House Committee on Energy and Commerce.
Anti-Racism in Public Health Act of 2025
Referred to the House Committee on Energy and Commerce.
SOAR Act of 2025
Read twice and referred to the Committee on Finance.